Anti-inflammatory function of 4-tert-butylphenyl salicylate through down-regulation of the NF-kappa B pathway

Archives of Pharmacal Research

Volumn 39, Issue 3, 2016, Pages 429-436

  Choi, Yun Hee ^a   Na, Baek Hee ^a   Choi, Yoon Seok ^a   Saifur Rahman, Md ^a   Kim, Mi Ri ^a   Jee, Jun Pil ^a   Shin, Jihoon ^a   Suh, Joo Won ^b   Yoo, Jin Cheol ^a  

^a Chosun University   (South Korea)

^b Myong Ji University   (South Korea)

Author keywords

4 tert Butylphenyl salicylate; Anti inflammatory effect; COX 2; iNOS; NF B pathway

Indexed keywords

4 TERT BUTYLPHENYL SALICYLATE; ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; NITRIC OXIDE; SALICYLIC ACID DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 4-TERT-BUTYLPHENYL SALICYLATE; I KAPPA B KINASE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL LINE RAW 264.7; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DOWN REGULATION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; INFLAMMATION; MACROPHAGE; MOUSE; MTT ASSAY; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CELL SURVIVAL; DRUG EFFECTS; METABOLISM; PHOSPHORYLATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL SURVIVAL; CELLS, CULTURED; CYCLOOXYGENASE 2; DOWN-REGULATION; I-KAPPA B KINASE; INTERLEUKIN-1BETA; INTERLEUKIN-6; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; SALICYLATES; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84957593482     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-015-0679-3     Document Type: Article

References (26)

1. An SJ, Pae HO, Oh GS, Choi BM, Jeong S, Jang SI, Oh H, Kwon TO, Song CE, Chung HT (2002) Inhibition of TNF-alpha, IL-1beta, and IL-6 productions and NF-kappa B activation in lipopolysaccharide-activated RAW 264.7 macrophages by catalposide, an iridoid glycoside isolated from Catalpa ovata G. Don (Bignoniaceae). Int Immunopharmacol 2:1173-1181
2. Cheon HJ, Rho YH, Choi SJ, Lee YH, Song GG, Sohn J, Won NH, Ji JD (2006) Prostaglandin E2 augments IL-10 signaling and function. J Immunol 177:1092-1100
3. Esposito E, Salvatore C (2007) The role of nitric oxide synthases in lung inflammation. Curr Opin Investig Drugs (London, England: 2000) 8:899-909
4. Farrow B, Evers BM (2002) Inflammation and the development of pancreatic cancer. Surg Oncol 10:153-169
5. Hacker H, Karin M (2006) Regulation and function of IKK and IKK-related kinases. Sci Stke 357:12-14
6. Hutchinson E (2003) An aspirin a day. Nat Rev Cancer 3:552
7. Jachak SM (2007) PGE synthase inhibitors as an alternative to COX-2 inhibitors. Curr Opin Investig Drugs (London, England: 2000) 8:411-415
8. Karin M (1999) How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 18:6867-6874
9. Karin M, Yixue C, Florian RG, Zhi-Wei L (2002) NF-κB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2:301-310
10. Kasama T, Miwa T, Isozaki T, Odai T, Adachi M, Kunkel S (2005) Neutrophil-derived cytokines: potential therapeutic targets in inflammation. Curr Drug Targets-Inflamm Allergy 4:273-279
11. Kim EH, Shim B, Kang S, Jeong G, Lee J, Yu YB, Chun M (2009) Anti-inflammatory effects of Scutellaria baicalensis extract via suppression of immune modulators and MAP kinase signaling molecules. J Ethnopharmacol 126:320-331
12. Klimp AH, Harry H, Claudia K, Ate GJ, Elisabeth GE, Toos D (2001) Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages. Cancer Res 61:7305-7309
13. Madan RK, Jacob L (2014) A review of toxicity from topical salicylic acid preparations. J Am Acad Dermatol 70:788-792
14. Min KR, Lee H, Kim BH, Chung EY, Cho SM, Kim Y (2005) Inhibitory effect of 6-hydroxy-7-methoxychroman-2-carboxylic acid phenylamide on nitric oxide and interleukin-6 production in macrophages. Life Sci 77:3242-3257
15. Mosser DM, Xia Z (2008) Interleukin-10: new perspectives on an old cytokine. Immunol Rev 226:205-218
16. Murakami A, Ohigashi H (2007) Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals. Int J Cancer 121:2357-2363
17. Nose F, Ichikawa T, Fujiwara M, Okayasu I (2002) Up-regulation of cyclooxygenase-2 expression in lymphocytic thyroiditis and thyroid tumors significant correlation with inducible nitric oxide synthase. Am J Clin Pathol 117:546-551
18. Ohshima H (2003) Genetic and epigenetic damage induced by reactive nitrogen species: implications in carcinogenesis. Toxicol Lett 140:99-104
19. Rajnakova A, Shabbir M, Goh PM, Ngoi SS (2001) Expression of nitric oxide synthase, cyclooxygenase, and p53 in different stages of human gastric cancer. Cancer Lett 172:177-185
20. Son HJ, Kim YH, Park D, Kim JJ, Rhee PL, Paik SW, Choi KW, Song SY, Rhee JC (2001) Interaction between cyclooxygenase-2 and inducible nitric oxide synthase in gastric cancer. J Clin Gastroenterol 33:383-388
21. Surh YJ, Na HK, Lee JY, Keum YS (2001) Molecular mechanisms underlying anti-tumor promoting activities of heat-processed Panax ginseng C.A, Meyer. J Korean Med Sci 16:38-41
22. Vane JR, Mitchell J, Appleton I, Tomlinson A, Bishop-Bailey D, Croxtall J, Willoughby Derek A (1994) Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci 91:2046-2050
23. Wadsworth TL, Dennis RK (1999) Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages. Biochem Pharmacol 57:941-949
24. Wolf AM, Wolf D, Rumpold H, Ludwiczek S, Enrich B, Gastl G, Weiss G, Herbert T (2005) The kinase inhibitor imatinib mesylate inhibits TNF-α production in vitro and prevents TNF-dependent acute hepatic inflammation. Proc Natl Acad Sci USA 102:13622-13627
25. Yinon BN, Karin M (2011) Inflammation meets cancer, with NF-[kappa] B as the matchmaker. Nat Immunol 12:715-723
26. Zeilhofer HU, Brune K (2006) Analgesic strategies beyond the inhibition of cyclooxygenases. Trends Pharmacol Sci 27:467-474